@article{fafc70c1095d422b90f425e91d966383,
title = "From One-Size-Fits-All to Mechanism-Guided Treatment for Intracranial Hemorrhage∗",
keywords = "aspirin, desmopressin, intracerebral hemorrhage, intracranial hemorrhage, platelets",
author = "Naidech, {Andrew M.}",
note = "Funding Information: *See also p. 1759. Key Words: aspirin; desmopressin; intracerebral hemorrhage; intracranial hemorrhage; platelets Dr. Naidech{\textquoteright}s institution received funding from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke. He disclosed that he had received royalties from the Society of Critical Care Medicine and the American Academy of Neurology for speaking, and he is listed as a Multiple Principal Investigator for a clinical trial of Factor VII, FVIIa for Acute hemorrhagic STroke administered at Earliest Time (FASTEST), slated to start in 2020; and he received support for article research from the NIH. Copyright {\textcopyright} 2019 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.",
year = "2019",
month = dec,
day = "1",
doi = "10.1097/CCM.0000000000004055",
language = "English (US)",
volume = "47",
pages = "1815--1816",
journal = "Critical care medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "12",
}